MiCAN Technologies, Inc.
Development of MylcEndo products for the LAL market using immortalized monocytic cells aMylc-Z
As of August, 2025
| City | Year of Establishment | Founder |
|---|---|---|
| Kyoto | 2016 | Kazuo Miyazaki |
| Partner VC | Latest round of Fundraising | Valuation |
|---|---|---|
| UntroD Capital Japan, Inc | Series B2 | Non-Disclosure |
- Contact Information: +81-75-381-3008
- info2@micantechnologies.com
- Website: MiCAN Technologies, Inc.
Program name
Deep-Tech Startups Support Program
Research theme
Development of MylcEndo products for the LAL market using immortalized monocytic cells aMylc-Z
Business Plan
With the development of new medicines and vaccines, the traditional pyrogen testing method used for pre-shipment testing is no longer suitable. Therefore, we are developing a new pyrogen testing product (MylcMAT product) based on immortalized monocyte aMylc cells, which can be deployed globally, as a new pyrogen testing method.
Research Outline
Our goal is to develop MylcEndo products using aMylc-Z cells into globally marketed products as an alternative to LAL testing. We aim to make MylcEndo products the global standard for daily quality testing.
- Improve and develop aMylc-Z cell production technology for high-cytokine-producing MAT tests.
- Design and develop MylcEndo products using aMylc-Z.
- Establish a mass production system for aMylc-Z cells.
- Product development of MylcEndo products.
- Japan-Europe Development: Development of MylcEndo products in Japan and Europe (promotion of European Pharmacopoeia-compliant evaluation) and completion of preparations for distribution.
- US Development: Development of MylcEndo products for the US market and preparation for launch.
| Phase | Business Area/Field | Research Period | Research Grant Amount |
|---|---|---|---|
| PCA | Healthcare | 2025-2027FY | Non-Disclosure |
International collaborative technology demonstration
| Countries/Regions | Collaborative activity outline |
|---|---|
| United States, Europe | The company plans to collaborate with a testing company that is a global player. It has established a European development office as a development base for completing the product for the European and US markets, and is continuing to consider providing prototypes to potential local customers from here as well as building a future supply chain. It has already established a local sales corporation (Germany). |
Last Updated : November 14, 2025